Counterfeit Drugs - New technology to combat counterfeit

A brand new and patented technology has recently been launched that protects patients from buying and using counterfeit medicines. Pharmaceutical companies can now effectively and very economically protect their products and supply chain with this technology, thus avoiding damages and incalculable liabilities resulting from falsified products.

Medication Errors In Hospitals Reduced By e-Prescribing

A study published in this week’s PLoS Medicine shows that commercial electronic prescribing systems (commonly known as e-prescribing, in which prescribers use a computer to order medications for their patients through a system with the help of prompts, aids, and alerts) could substantially reduce prescribing error rates in hospital in-patients…

HPV Vaccine Policy: At Odds With Evidence-Based Medicine?

According to a new study, there is a major discrepancy in claims regarding the safety and efficacy of the human papillomavirus (HPV) vaccines. Medscape Medical News

Anti-HER2 dendritic cell vaccine shows promise against DCIS

Researchers at the Perelman School of Medicine at the University of Pennsylvania report that a short course of vaccination with an anti-HER2 dendritic cell vaccine made partly from the patient’s own cells triggers a complete tumor eradication in nearly 20 percent of women with ductal carcinoma in situ (DCIS), an early breast cancer.

Allos seeks re-examination of EMA CHMP opinion on FOLOTYN for PTCL

Allos Therapeutics, Inc. today announced that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative opinion issued in January by the EMA’s Committee For Medicinal Products for Human Use (CHMP) for conditional approval of FOLOTYN (pralatrexate injection) for the treatment of patients with peripheral T-cell lymphoma (PTCL) [...]

New discovery paves way for genetic screening test

Researchers at the Columbia University College of Dental Medicine have identified a genetic variation that raises the risk of developing serious necrotic jaw bone lesions in patients who take bisphosphonates, a common class of osteoclastic inhibitors.

‘Guest Authors’ Could Face Legal Trouble

(MedPage Today) — Prominent researchers who allow themselves to be listed as authors of ghostwritten journal articles could find themselves in a world of legal hurt, an essay in PLoS Medicine argued.

AstraZeneca donation to benefit poor and uninsured Americans

AstraZeneca, the global biopharmaceutical company, has donated $3.8 million worth of prescription medicines to AmeriCares for chronically ill Americans who rely on safety net clinics for their medical care. The donation is one of the largest AmeriCares received in the past year for its domestic aid deliveries.

FDA approves Genzyme’s Fabrazyme manufacturing plant in Framingham

Genzyme, a Sanofi company, announced today that the Food and Drug Administration (FDA) has approved its manufacturing plant in Framingham, Mass., for the production of Fabrazyme(agalsidase beta). This follows the previously announced approval by the European Medicines Agency (EMA) last week.

Study Of Electronic Medical Records Reveals That Women Report Feeling Pain More Intensely Than Men

Women report more-intense pain than men in virtually every disease category, according to Stanford University School of Medicine investigators who mined a huge collection of electronic medical records to establish the broad gender difference to a high level of statistical significance…